^{* All development phases not applicable for 505(b)2 regulatory filings.}

^{** See warnings and full prescribing information. Marketed in the U.S. by Meda Pharmaceuticals.}

^{*** Licensed worldwide to Endo Health Solutions.}

Dr. Mark A. Sirgo will be presenting at the

William Blair 33rd Annual Growth Stock Conference

Tuesday, June 11, 2013 at 2:10 PM CT

Click Here for the Webcast

_______________________________

BioDelivery Sciences International

R&D DAY

Thursday, March 7, 2013 at 12:00 Noon, ET

Click Here for Live Webcast of Presentation

 Treatment of Pain and Opioid Dependence with Buprenorphine

   Speakers

 Joseph Pergolizzi, MD

Pain Medicine Specialist

Assistant Professor of Medicine

Johns Hopkins School of Medicine

 Gregory Sullivan, MD

Addiction Medicine Specialist

Parkway Medical Center

Birmingham, Alabama

 Genie L Bailey, MD

Psychiatrist/Addiction Medicine Specialist

Medical Director, Stanley St. Treatment and Resources (SSTAR)

 Faculty, Brown University

________________________________________